$95.90
1.19% today
Nasdaq, Mar 26, 09:00 pm CET
ISIN
US09075V1026
Symbol
BNTX
Sector
Industry

BioNTech SE - ADR Target price 2025 - Analyst rating & recommendation

BioNTech SE - ADR Classifications & Recommendation:

Buy
74%
Hold
26%

BioNTech SE - ADR Price Target

Target Price $138.72
Price $95.90
Potential
Number of Estimates 20
20 Analysts have issued a price target BioNTech SE - ADR 2026 . The average BioNTech SE - ADR target price is $138.72. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 17 Analysts recommend BioNTech SE - ADR to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioNTech SE - ADR stock has an average upside potential 2026 of . Most analysts recommend the BioNTech SE - ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 2.98 2.31
27.92% 22.48%
EBITDA Margin -12.56% -66.69%
144.03% 431.18%
Net Margin -24.11% -46.32%
199.24% 92.11%

19 Analysts have issued a sales forecast BioNTech SE - ADR 2025 . The average BioNTech SE - ADR sales estimate is

$2.3b
Unlock
. This is
22.56% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.0b 0.04%
Unlock
, the lowest is
$2.1b 30.30%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $3.0b 27.92%
2025
$2.3b 22.48%
Unlock
2026
$2.5b 9.51%
Unlock
2027
$2.5b 0.64%
Unlock
2028
$3.1b 22.13%
Unlock
2029
$3.9b 27.71%
Unlock

12 Analysts have issued an BioNTech SE - ADR EBITDA forecast 2025. The average BioNTech SE - ADR EBITDA estimate is

$-1.5b
Unlock
. This is
315.13% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-867m 133.87%
Unlock
, the lowest is
$-2.3b 515.16%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-374m 131.73%
2025
$-1.5b 311.79%
Unlock
2026
$-1.7b 11.35%
Unlock
2027
$-1.8b 6.98%
Unlock
2028
$-1.5b 16.08%
Unlock
2029
$-287m 81.32%
Unlock

EBITDA Margin

2024 -12.56% 144.03%
2025
-66.69% 431.18%
Unlock
2026
-67.81% 1.68%
Unlock
2027
-73.01% 7.67%
Unlock
2028
-50.17% 31.28%
Unlock
2029
-7.34% 85.37%
Unlock

10 BioNTech SE - ADR Analysts have issued a net profit forecast 2025. The average BioNTech SE - ADR net profit estimate is

$-1.1b
Unlock
. This is
47.44% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-434m 40.14%
Unlock
, the lowest is
$-2.0b 179.93%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-718m 171.53%
2025
$-1.1b 48.92%
Unlock
2026
$-1.2b 8.23%
Unlock
2027
$-1.1b 1.96%
Unlock
2028
$-585m 48.37%
Unlock
2029
$-255m 56.50%
Unlock

Net Margin

2024 -24.11% 199.24%
2025
-46.32% 92.11%
Unlock
2026
-45.78% 1.17%
Unlock
2027
-45.17% 1.33%
Unlock
2028
-19.10% 57.72%
Unlock
2029
-6.50% 65.97%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.99 -4.45
171.53% 48.83%
P/E negative
EV/Sales 2.89

10 Analysts have issued a BioNTech SE - ADR forecast for earnings per share. The average BioNTech SE - ADR EPS is

$-4.45
Unlock
. This is
47.35% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.81 40.07%
Unlock
, the lowest is
$-8.45 179.80%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.99 171.53%
2025
$-4.45 48.83%
Unlock
2026
$-4.82 8.31%
Unlock
2027
$-4.72 2.07%
Unlock
2028
$-2.44 48.31%
Unlock
2029
$-1.06 56.56%
Unlock

P/E ratio

Current -32.15 507.99%
2025
-21.80 32.19%
Unlock
2026
-20.14 7.61%
Unlock
2027
-20.54 1.99%
Unlock
2028
-39.79 93.72%
Unlock
2029
-91.47 129.88%
Unlock

Based on analysts' sales estimates for 2025, the BioNTech SE - ADR stock is valued at an EV/Sales of

and an P/S ratio of
10.10
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.24 0.45%
2025
2.89 28.95%
Unlock
2026
2.64 8.68%
Unlock
2027
2.65 0.64%
Unlock
2028
2.17 18.12%
Unlock
2029
1.70 21.70%
Unlock

P/S ratio

Current 7.82 47.45%
2025
10.10 29.13%
Unlock
2026
9.22 8.68%
Unlock
2027
9.28 0.64%
Unlock
2028
7.60 18.12%
Unlock
2029
5.95 21.70%
Unlock

Current BioNTech SE - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup
Locked
Locked
Locked Mar 13 2025
BMO Capital
Locked
Locked
Locked Mar 11 2025
Morgan Stanley
Locked
Locked
Locked Mar 11 2025
Canaccord Genuity
Locked
Locked
Locked Mar 11 2025
Truist Securities
Locked
Locked
Locked Jan 10 2025
Wells Fargo
Locked
Locked
Locked Dec 11 2024
Canaccord Genuity
Locked
Locked
Locked Nov 27 2024
Analyst Rating Date
Locked
Citigroup:
Locked
Locked
Mar 13 2025
Locked
BMO Capital:
Locked
Locked
Mar 11 2025
Locked
Morgan Stanley:
Locked
Locked
Mar 11 2025
Locked
Canaccord Genuity:
Locked
Locked
Mar 11 2025
Locked
Truist Securities:
Locked
Locked
Jan 10 2025
Locked
Wells Fargo:
Locked
Locked
Dec 11 2024
Locked
Canaccord Genuity:
Locked
Locked
Nov 27 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today